Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey.

BACKGROUND Rapid uptake of prostate-specific antigen (PSA) testing has occurred in the United States despite inconclusive evidence regarding mortality benefit. METHODS We examined data (n=927) from the 2003 Health Information National Trends Survey to assess prevalence of self-reported PSA use and its association with patients' decision making. RESULTS Over half (55.2%) the sample reported ever having had a PSA test. Men aged 65-74 (OR=2.53, 1.49-4.31), with some college (OR=2.41, 1.22-4.77) or college degrees (OR=5.01, 2.53-9.90) were more likely to have had PSA tests, while men without health insurance (OR=0.32, 0.12-0.88) or a usual source of care (OR=0.35, 0.22-0.54) were less likely. In a model including healthcare provider communication and information seeking, men who reported that providers involved them in decisions (OR=1.76, 1.02-3.03) and recommended PSA (OR=236.3, 70.5-791.4) were more likely to have had the tests. Men aged 65-74 (OR=2.30, 1.33-4.00), with college degrees (OR=2.91, 1.45-5.82), and greater information attention/seeking (OR=1.23, 1.07-1.40) were more likely to report PSA recommendations, while those without usual care were less likely (OR=0.37, 0.22-0.64). Men without usual care (OR=0.38, 0.20-0.71) and Hispanic men (OR=0.40, 0.19-0.85) were less likely to report that healthcare providers involved them in healthcare decisions. CONCLUSIONS Results emphasize the relevance of patient decision making and the importance of healthcare providers in PSA testing.

[1]  Kathleen N Lohr,et al.  Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force , 2002, Annals of Internal Medicine.

[2]  R. Hiatt,et al.  Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non-Hispanic white health plan members in northern California. , 1995, Preventive medicine.

[3]  R. Luckmann,et al.  Healthcare system factors and colorectal cancer screening. , 2002, American journal of preventive medicine.

[4]  K. Bucholz,et al.  Sociodemographic and health status characteristics associated with prostate cancer screening in a national cohort of middle-aged male veterans , 1999 .

[5]  R. Merrill.  Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah. , 2001, Preventive medicine.

[6]  S. Fox,et al.  The Technology Of Mammography: Misunderstood and Underutilized , 1988, International Journal of Technology Assessment in Health Care.

[7]  J. Oesterling,et al.  Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program. , 1995, Urology.

[8]  Daniel S. Miller,et al.  Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[9]  R. Volk,et al.  Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions? , 1999, The Journal of family practice.

[10]  S. Fox,et al.  The Effect of Physician-Patient Communication on Mammography Utilization by Different Ethnic Groups , 1991, Medical care.

[11]  E. Weitzman,et al.  Risk and reluctance: understanding impediments to colorectal cancer screening. , 2001, Preventive medicine.

[12]  D. Wood,et al.  Screening for prostate cancer. The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness. , 1999, The Medical clinics of North America.

[13]  R. Hiatt,et al.  Concordance of self-reported data and medical record audit for six cancer screening procedures. , 1993, Journal of the National Cancer Institute.

[14]  U. P. S. T. Force,et al.  Screening for prostate cancer: recommendations and rationale. , 2003, American family physician.

[15]  Robert M. Kaplan,et al.  Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test , 2001, Journal of General Internal Medicine.

[16]  Nisha Gandhi,et al.  Promoting informed decisions about cancer screening in communities and healthcare systems. , 2004, American journal of preventive medicine.

[17]  S. Vernon,et al.  Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? , 2003, American journal of public health.

[18]  S. Vernon,et al.  Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. , 2004, American journal of public health.

[19]  Stacey L Sheridan,et al.  Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force. , 2004, American journal of preventive medicine.

[20]  T. Ricketts,et al.  The role of physician recommendation in women's mammography use: is it a 2-stage process? , 2000, Medical care.

[21]  R. Volk,et al.  The accuracy of primary care patients' self-reports of prostate-specific antigen testing. , 2002, American journal of preventive medicine.

[22]  Dean Schillinger,et al.  Physician language ability and cultural competence , 2004, Journal of General Internal Medicine.

[23]  S. Vernon,et al.  Participation in colorectal cancer screening: a review. , 1997, Journal of the National Cancer Institute.

[24]  E. Feuer,et al.  Screening mammography: a missed clinical opportunity? Results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey Studies. , 1990, JAMA.

[25]  P. Wingo,et al.  Comparison of mammography and Pap test use from the 1987 and 1992 National Health Interview Surveys: are we closing the gaps? , 1996, American journal of preventive medicine.

[26]  Nancy Breen,et al.  Progress in cancer screening practices in the United States , 2003, Cancer.

[27]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. , 2003, Journal of the National Cancer Institute.

[28]  M. Elliott,et al.  Confirmatory factor analysis of the Consumer Assessment of Health Plans Study (CAHPS) 1.0 Core Survey. , 2001, Psychological assessment.

[29]  S. Vernon,et al.  Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing , 2003, Journal of general internal medicine.

[30]  T. Wilt,et al.  Screening for prostate cancer. , 2013, The Cochrane database of systematic reviews.

[31]  L. Seeff,et al.  Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. , 2002, Preventive medicine.

[32]  R A Stephenson,et al.  Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.

[33]  P. Gimotty,et al.  Factors affecting participation in a mammography screening program among members of an urban Detroit health maintenance organization. , 1998, Cancer detection and prevention.

[34]  R. Wender.  Barriers to screening for colorectal cancer. , 2002, Gastrointestinal endoscopy clinics of North America.

[35]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[36]  K. King,et al.  The validity of male patients' self-reports regarding prostate cancer screening. , 1999, Preventive medicine.

[37]  L. Caplan,et al.  Trends in mammography use and their relation to physician and other factors. , 1996, Cancer detection and prevention.

[38]  D K Wagener,et al.  Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. , 2001, Journal of the National Cancer Institute.

[39]  Michael J Barry,et al.  Health Decision Aids To Facilitate Shared Decision Making in Office Practice , 2002, Annals of Internal Medicine.

[40]  B. Rimer.  Current use and how to increase mammography screening in women. , 1997, Surgical Oncology Clinics of North America.

[41]  Daniel S. Miller,et al.  Knowledge, attitudes, and screening practices among older men regarding prostate cancer. , 2000, American journal of public health.

[42]  Gary L. Kreps,et al.  The Health Information National Trends Survey (HINTS): Development, Design, and Dissemination , 2004, Journal of health communication.

[43]  A. Kristal,et al.  Associations of demographic and health-related characteristics with prostate cancer screening in Washington State. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  G. A. Alexander,et al.  Racial/ethnic patterns of cancer in the United States, 1988-1992. , 1996 .

[45]  J. Preisser,et al.  Factors influencing use of the prostate-specific antigen screening test in primary care. , 2000, The American journal of managed care.

[46]  L Kessler,et al.  Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys. , 1994, American journal of public health.

[47]  S. Taplin,et al.  Conflicting National Recommendations and the Use of Screening Mammography: Does the Physician's Recommendation Matter? , 1997, The Journal of the American Board of Family Medicine.

[48]  J A Stein,et al.  The importance of physician communication on breast cancer screening of older women. , 1994, Archives of internal medicine.

[49]  C. Coley,et al.  CLINICAL GUIDELINES: PART II: Early Detection of Prostate Cancer: Part II , 1997, Annals of Internal Medicine.

[50]  S Sudman,et al.  Cognitive aspects of recalling and reporting health-related events: Papanicolaou smears, clinical breast examinations, and mammograms. , 1997, American journal of epidemiology.

[51]  E. Funkhouser,et al.  Compliance with mammography guidelines: physician recommendation and patient adherence. , 1999, Preventive medicine.

[52]  S. Woolf.  Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. , 1995, The New England journal of medicine.